Abiopharma

🔍 FIDELITY & GUARANTY LIFE INSURANCE CO (Executive)

Company: Crescent Capital BDC, Inc. (CCAP)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Sold 11,285 shares of Common Stock at $10.5 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,006,279.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 45,000 shares of Common Stock at $10.4448 per share (Direct)
  Date: 2026-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,961,279.00 | transaction_form_type: 4 | Footnotes: F3, F2

Footnotes:

• F1: The shares were sold in multiple transactions at prices ranging from $10.48 to $10.59 per share. The price reported reflects the volume weighted average price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
• F2: Represents shares of common stock held by Fidelity & Guaranty Life Insurance Company of New York, a wholly owned subsidiary of the Reporting Person.
• F3: The shares were sold in multiple transactions at prices ranging from $10.38 to $10.51 per share. The price reported reflects the volume weighted average price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.